ANI Pharmaceuticals Director Sells Over $1.1 Million Worth Of Company Shares
ANI Pharmaceuticals Inc. director Patrick D. Walsh has sold company shares worth more than $1.13 million, according to a recent filing with the US Securities and Exchange Commission (SEC).
The stock sale took place over two separate transactions earlier this week. On May 11, Walsh sold 3,973 shares at a price of $80.75 per share. He later sold another 10,000 shares on May 13, with the share price ranging between $80.63 and $80.75.
Following the transactions, Walsh continues to hold 38,432 shares in ANI Pharmaceuticals.
The insider sale comes at a time when ANI Pharmaceuticals shares have shown strong performance in the market. The company’s stock has gained nearly 34% over the past year and was recently trading around $80.88 per share.
Market analysts noted that despite the recent insider selling activity, the company continues to maintain a strong financial position. Reports suggest ANI Pharmaceuticals currently holds a healthy financial score and has delivered strong long-term returns for investors over the past five years.
The company also recently reported better-than-expected earnings for the first quarter of 2026. ANI Pharmaceuticals posted earnings per share (EPS) of $2.05, significantly above analyst estimates of $1.45. Revenue also surpassed market expectations, reaching $237.5 million against forecasts of $213.42 million.
The strong quarterly performance has helped reinforce investor confidence in the pharmaceutical company, even as insider stock sales attract attention in financial markets.
News source: Information for this article was gathered from a variety of reliable news outlets
